ProfessorRobert Vandenberg
Level 3 Supervisor, Molecular Biomedicine Theme
Faculty of Medicine and Health
Orcid identifier0000-0003-1523-4814 (opens in a new tab)
- Level 3 Supervisor, Molecular Biomedicine ThemeFaculty of Medicine and Health
Research projects & supervision summary
Design and development of novel compounds that inhibit glycine transporters for the treatment of pain.
Identification of dual action allosteric glycine transport inhibitors/glycine receptor stimulators for the treatment of pain
Identify mitocides for the treatment of Varroa mites to protect Honeybees
RESEARCH PROJECTS & ACTIVITIES
- RESEARCH-BASED DEGREE SUPERVISIONCharacterisation of Novel Glutamate Transporter Homologues from Caenorhabditis elegans
- RESEARCH-BASED DEGREE SUPERVISIONDual Action Modulators of the Glycinergic Synapse
- RESEARCH-BASED DEGREE SUPERVISIONExploring the elevator mechanism of the glutamate transporter family: link to function and disease
- RESEARCH-BASED DEGREE SUPERVISIONFrom cells to mice and back again: Designing a series of GlyT2 inhibitors for the treatment of neuropathic pain
- RESEARCH-BASED DEGREE SUPERVISIONFrom Molecules to Therapeutics - Developing Allosteric Inhibitors of the Solute Carrier 6 Transporters for Neurological Applications.
- RESEARCH-BASED DEGREE SUPERVISIONFunctional and structural characterisation of the glycine transporter 2
- RESEARCH-BASED DEGREE SUPERVISIONFunctional characterisation of the glutamine transporter ASCT2 and its potential as a molecular target in cancer therapy
- RESEARCH-BASED DEGREE SUPERVISIONInvestigating the molecular mechanism of bioactive lipid inhibitors of GlyT2
- RESEARCH-BASED DEGREE SUPERVISIONLipid Modulators of glycine receptors and their potential use for pain therapies
- RESEARCH-BASED DEGREE SUPERVISIONPharmacological modulation of the glutamate transporter chloride channel
- RESEARCH-BASED DEGREE SUPERVISIONStructural basis for the dual transport-channel functions of SLC1A transporters
- RESEARCH-BASED DEGREE SUPERVISIONUnraveling the molecular mechanisms of transporters from the SLC1A family and elucidating links to dysfunction in brain disease